NO20053344L - Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser. - Google Patents

Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser.

Info

Publication number
NO20053344L
NO20053344L NO20053344A NO20053344A NO20053344L NO 20053344 L NO20053344 L NO 20053344L NO 20053344 A NO20053344 A NO 20053344A NO 20053344 A NO20053344 A NO 20053344A NO 20053344 L NO20053344 L NO 20053344L
Authority
NO
Norway
Prior art keywords
genetically modified
generating
organism
modified organism
active substances
Prior art date
Application number
NO20053344A
Other languages
English (en)
Other versions
NO20053344D0 (no
Inventor
Almut Nitsche
Ekkehard Leberer
Bert Klebl
Anja Stadler
Rosemarie Sollner
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20053344L publication Critical patent/NO20053344L/no
Publication of NO20053344D0 publication Critical patent/NO20053344D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/60—New or modified breeds of invertebrates
    • A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20053344A 2002-12-17 2005-07-08 Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser. NO20053344D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10258885A DE10258885A1 (de) 2002-12-17 2002-12-17 Verfahren zur Generierung eines gentechnisch veränderten Organismus
PCT/EP2003/012870 WO2004055206A1 (de) 2002-12-17 2003-11-18 Verfahren zur generierung eines gentechnisch veränderten organismus für das wirk substanzscreening

Publications (2)

Publication Number Publication Date
NO20053344L true NO20053344L (no) 2005-07-08
NO20053344D0 NO20053344D0 (no) 2005-07-08

Family

ID=32519000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053344A NO20053344D0 (no) 2002-12-17 2005-07-08 Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser.

Country Status (13)

Country Link
US (1) US20040143854A1 (no)
EP (1) EP1576186B1 (no)
JP (1) JP4630067B2 (no)
KR (2) KR20120038025A (no)
CN (1) CN1726290B (no)
AT (1) ATE508201T1 (no)
AU (1) AU2003283409A1 (no)
CA (1) CA2509333A1 (no)
DE (2) DE10258885A1 (no)
NO (1) NO20053344D0 (no)
RU (1) RU2376364C2 (no)
WO (1) WO2004055206A1 (no)
ZA (1) ZA200504212B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP1774017B1 (en) 2004-07-26 2013-05-15 Pfenex Inc. Process for improved protein expression by strain engineering
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
US20070197532A1 (en) * 2005-11-18 2007-08-23 Cao Sheldon X Glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
WO2007124115A2 (en) * 2006-04-20 2007-11-01 Trustees Of Boston College Compositions and methods for identifying inhibitors and activators of cyclic amp phosphodiesterases
JP5386350B2 (ja) * 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) * 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN103179851B (zh) * 2010-10-29 2016-08-03 弗·哈夫曼-拉罗切有限公司 具有il33n端结构域缺失的鼠炎症模型
HUP1100657A2 (en) * 2011-11-29 2013-06-28 Eotvos Lorand Tudomanyegyetem Transgenic caenorhabditis elegans
CN110172454B (zh) * 2019-05-23 2020-11-13 浙江大学 一种s-腺苷甲硫氨酸合成酶突变体及其高通量筛选方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030012A1 (en) * 1994-04-26 1995-11-09 Cadus Pharmaceutical Corporation Functional expression of mammalian adenylyl cyclase in yeast
JP2001507581A (ja) * 1997-11-07 2001-06-12 アイコニックス・ファーマシューティカルズ・インコーポレーテッド 代用遺伝学的標的解析法
EP1141416A1 (en) * 1998-12-31 2001-10-10 Iconix Pharmaceuticals, Inc. Method for generating a pathway reporter system
US20010031461A1 (en) * 1999-12-22 2001-10-18 Stuart Tugendreich Synthetic lethal expression screen
CA2437383A1 (en) * 2001-02-02 2002-08-15 Raymond Kim Alteration of phenotype due to heterologous genes
US20030044866A1 (en) * 2001-08-15 2003-03-06 Charles Boone Yeast arrays, methods of making such arrays, and methods of analyzing such arrays

Also Published As

Publication number Publication date
CN1726290B (zh) 2012-09-05
KR20050085806A (ko) 2005-08-29
AU2003283409A1 (en) 2004-07-09
RU2005122470A (ru) 2006-05-10
JP2006509512A (ja) 2006-03-23
CN1726290A (zh) 2006-01-25
WO2004055206A1 (de) 2004-07-01
RU2376364C2 (ru) 2009-12-20
US20040143854A1 (en) 2004-07-22
EP1576186A1 (de) 2005-09-21
HK1087734A1 (en) 2006-10-20
ZA200504212B (en) 2006-02-22
KR101215854B1 (ko) 2012-12-31
EP1576186B1 (de) 2011-05-04
JP4630067B2 (ja) 2011-02-09
CA2509333A1 (en) 2004-07-01
KR20120038025A (ko) 2012-04-20
ATE508201T1 (de) 2011-05-15
NO20053344D0 (no) 2005-07-08
DE10258885A1 (de) 2004-07-15
DE50313671D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
NO20053344D0 (no) Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser.
ATE269414T1 (de) Verfahren zur drogenuntersuchung
DE60034059D1 (de) Zielgerichtete verfahren des wirkstoff screenings unter verwendung von co-kultivierungs verfahren
ATE516497T1 (de) Screening für funktionshomologien
DE60336419D1 (de) Selektive synthese von organophosphiten
ATE397752T1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
DE60232059D1 (de) Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
WO2004065560A3 (en) Methods of screening for modulators of nerve growth factor
Zhou et al. A versatile approach to pyrrolidine azasugars and homoazasugars based on a highly diastereoselective reductive benzyloxymethylation of protected tartarimide
DE69421624D1 (de) Medikamente bindendes protein
ATE351902T1 (de) Oberflächentransfektion und expressionsverfahren
DE60332993D1 (de) Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung
ATE217905T1 (de) Zellinien, die einen biologisch aktiven faktor-ix exprimieren
Mackey et al. Mechanical modulation, physiological roles, and imaging innovations of intercellular calcium waves in living systems
EP1427830A4 (en) BV8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
WO2002101039A1 (fr) Procede de test de medicament destine a traiter ou a prevenir des maladies telles que l'hyperlipemie
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
SE0201763D0 (sv) Anordning för multipel simultan genöverföring
SE0002189D0 (sv) New method and assay
CY1108849T1 (el) Πολλαπλασιαμος του ιου κορωνα των βοοειδων σε κυτταρα ωοθηκων κινεζικων κρικητων
WO2003094841A3 (en) Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
Sohail Gene silencing by RNA interference: technology and application
ATE403739T1 (de) Verfahren zur verwendung teilungsarretierter zellen in screening-assays
AU2003241174A1 (en) Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
DE60304065D1 (de) Optimierte proteinsynthese

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application